Wealthspire Advisors (New York)’s Labcorp LH Stock Holding History

Wealthspire Advisors (New York)’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$890K	Buy	3,178 +286	+10%	+$75.2K	﹤0.01%	582
2026 Q1	$772K	Sell	2,892 -363	-11%	-$98.3K	0.01%	459
2025 Q4	$817K	Buy	3,255 +1,101	+51%	+$292K	0.01%	474
2025 Q3	$618K	Sell	2,154 -7	-0.3%	-$1.88K	﹤0.01%	487
2025 Q2	$567K	Sell	2,161 -1,596	-42%	-$389K	﹤0.01%	505
2025 Q1	$874K	Sell	3,757 -87	-2%	-$21.1K	0.01%	400
2024 Q4	$882K	Buy	3,844 +233	+6%	+$53.5K	0.01%	397
2024 Q3	$807K	Buy	3,611 +115	+3%	+$25.3K	0.01%	404
2024 Q2	$711K	Sell	3,496 -49	-1%	-$9.97K	0.01%	369
2024 Q1	$774K	Sell	3,545 -62	-2%	-$13.7K	0.01%	349
2023 Q4	$820K	Sell	3,607 -218	-6%	-$45.8K	0.01%	345
2023 Q3	$769K	Sell	3,825 -525	-12%	-$111K	0.01%	322
2023 Q2	$902K	Sell	4,350 -1	-0%	-$194	0.01%	263
2023 Q1	$858K	Sell	4,351 -224	-5%	-$46.1K	0.01%	274
2022 Q4	$925K	Buy	4,575 +56	+1%	+$10.9K	0.02%	276
2022 Q3	$795K	Hold	4,519	–	–	0.02%	260
2022 Q2	$910K	Buy	4,519 +28	+0.6%	+$5.97K	0.02%	220
2022 Q1	$1.02M	Sell	4,491 -341	-7%	-$80.2K	0.02%	194
2021 Q4	$1.3M	Sell	4,832 -333	-6%	-$82.4K	0.03%	194
2021 Q3	$1.25M	Buy	5,165 +665	+15%	+$168K	0.03%	219
2021 Q2	$1.07M	Sell	4,500 -4,704	-51%	-$1.07M	0.03%	157
2021 Q1	$2.02M	Buy	9,204 +4,669	+103%	+$937K	0.05%	173
2020 Q4	$793K	Buy	+4,535	New	+$783K	0.02%	235
2020 Q2	–	Sell	-7,287	Closed	-$791K	–	423
2020 Q1	$791K	Buy	+7,287	New	+$1.05M	0.03%	230
2019 Q1	–	Sell	-151	Closed	-$16K	–	467
2018 Q4	$16K	Buy	+151	New	+$20.2K	﹤0.01%	392

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wealthspire Advisors (New York)'s LH Position: Q2 2026 in Review

Wealthspire Advisors (New York) increased its Labcorp (LH) stake by 9.9% in Q2 2026, buying an estimated $75.2K and bringing the position to 3,178 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #582.

Wealthspire Advisors (New York) first reported a position in LH in Q4 2018 and has held it in 25 quarters since. The position peaked at $2.02M in Q1 2021. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Wealthspire Advisors (New York) held 3,178 shares of Labcorp worth $890K as of Q2 2026.
Wealthspire Advisors (New York) bought 286 Labcorp shares in Q2 2026, an estimated $75.2K.
Labcorp made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #582 holding.
Wealthspire Advisors (New York) first reported a position in Labcorp in Q4 2018 and has held it in 25 quarters since.
Wealthspire Advisors (New York)'s Labcorp position peaked at $2.02M in Q1 2021.
1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.